A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 23, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2027, filed Sep 8, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the PATH SEC filings page.
UiPath, Inc. (PATH) reported $1.7B in revenue over the twelve months to Jul 31, 2026, up 15.0% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
UiPath reached operating profitability as disciplined overhead and low reinvestment converted growth into cash, while its liquidity cushion narrowed.
From FY2025 to FY2026, revenue grew12.7% while SG&A fell6.9% . That cost shape helped operating margin move from-11.4% to3.5% , indicating the earnings inflection came more from overhead absorption than gross-margin expansion.
FY2026 operating cash flow of
The current ratio narrowed from 4.3x in FY2022 to 2.5x in FY2026, reducing the short-term cushion. FY2026 liabilities of
Financial Health Signals
Scored against operating companies for FY2026. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of UiPath, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
UiPath, Inc. has an operating margin of 3.5%, meaning the company retains $4 of operating profit per $100 of revenue. Among its peers this margin ranks in the lower range, for a profitability score of 27/100. This is up from -11.4% the prior year.
UiPath, Inc.'s revenue grew 12.7% year-over-year to $1.6B, a solid pace of expansion. This earns a growth score of 67/100.
With a current ratio of 2.48, UiPath, Inc. holds $2.48 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 70/100.
UiPath, Inc. converts 21.9% of revenue into free cash flow ($352.2M). This strong cash generation earns a score of 88/100.
UiPath, Inc.'s ROE of 13.6% shows moderate profitability relative to equity, earning a score of 30/100. This is up from -4.0% the prior year.
UiPath, Inc. scores 4.35, well above the 2.99 safe threshold. The largest contribution to the score comes from a market capitalization of $7.4B against total liabilities of $1.1B. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
UiPath, Inc. passes 6 of 7 computable financial strength tests (2 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.
For every $1 of reported earnings, UiPath, Inc. generates $1.31 in operating cash flow ($371.2M OCF vs $282.3M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Key Financial Metrics
Earnings & Revenue
UiPath, Inc. generated $410.3M in revenue in Q2 2027. This represents an increase of 13.4% from the same quarter a year earlier. Against the prior quarter it is down 1.9%.
UiPath, Inc.'s EBITDA was $39.9M in Q2 2027, measuring earnings before interest, taxes, depreciation, and amortization. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. Against the prior quarter it is up 12.4%.
UiPath, Inc. reported $36.1M in net income in Q2 2027. This represents an increase of 2178.3% from the same quarter a year earlier. Against the prior quarter it is up 60.2%.
UiPath, Inc. earned $0.07 per diluted share (EPS) in Q2 2027. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. Against the prior quarter it is up 75.0%.
Cash & Balance Sheet
UiPath, Inc. generated $29.3M in free cash flow in Q2 2027, representing cash available after capex. This represents a decrease of 29.5% from the same quarter a year earlier. Against the prior quarter it is down 77.3%.
UiPath, Inc. held $607.4M in cash as of Q2 2027; no long-term debt figure is on record for that period.
Not reported for Q2 2027.
Margins & Returns
UiPath, Inc.'s gross margin was 80.4% in Q2 2027, indicating the percentage of revenue retained after direct costs. This is down 1.8 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.3 percentage points.
UiPath, Inc.'s operating margin was 7.7% in Q2 2027, reflecting core business profitability. This is up 13.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.0 percentage points.
UiPath, Inc.'s net profit margin was 8.8% in Q2 2027, showing the share of revenue converted to profit. This is up 8.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 3.4 percentage points.
UiPath, Inc.'s quarterly ROE was 1.8% in Q2 2027: one quarter's net income over shareholder equity, not annualized. This is up 1.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.7 percentage points.
Capital Allocation
UiPath, Inc. invested $83.4M in research and development in Q2 2027. This represents a decrease of 15.2% from the same quarter a year earlier. Against the prior quarter it is down 10.2%.
UiPath, Inc. spent $24.8M on share buybacks in Q2 2027, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 75.6% from the same quarter a year earlier. Against the prior quarter it is down 89.8%.
UiPath, Inc. invested $1.4M in capex in Q2 2027, funding long-term assets and infrastructure. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. Against the prior quarter it is down 48.2%.
PATH Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2710-Q | Q1'2710-Q | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $410.3M+13.4% | $418.4M+17.3% | $481.1M+13.6% | $411.1M+15.9% | $361.7M+14.4% | $356.6M+6.4% | $423.6M+4.5% | $354.7M+8.8% |
| Cost of Revenue | $80.6M+25.2% | $76.9M+20.5% | $73.9M+14.6% | $68.8M+7.9% | $64.4M+1.7% | $63.9M+15.4% | $64.5M+21.0% | $63.8M+27.7% |
| Gross Profit | $329.7M+10.9% | $341.5M+16.6% | $407.2M+13.4% | $342.3M+17.7% | $297.3M+17.6% | $292.8M+4.6% | $359.1M+2.0% | $290.9M+5.4% |
| R&D Expenses | $83.4M-15.2% | $92.9M-2.0% | $95.2M-4.5% | $96.9M-0.1% | $98.3M-0.1% | $94.8M+10.8% | $99.7M+16.4% | $97.0M+14.7% |
| SG&A Expenses | $214.7M-2.1% | $220.6M+2.9% | $231.7M+2.6% | $232.4M-2.1% | $219.2M-15.0% | $214.3M-12.0% | $225.8M-10.1% | $237.3M-4.1% |
| Operating Income | $31.6Mn/m | $28.0Mn/m | $80.3M+138.9% | $13.1Mn/m | -$20.2Mn/m | -$16.4Mn/m | $33.6M+122.6% | -$43.4Mn/m |
| EBITDA | $39.9Mn/m | $35.5Mn/m | $86.7M+127.9% | $16.9Mn/m | -$16.7Mn/m | -$13.2Mn/m | $38.0M+70.8% | -$39.6Mn/m |
| Income Tax | $16.8M+861.9% | $18.4M+552.4% | -$12.0M-524.9% | -$174.2Mn/m | $1.7M-54.5% | $2.8M-25.2% | $2.8M+5.6% | -$14.8M-478.1% |
| Net Income | $36.1M+2178.3% | $22.5Mn/m | $104.5M+101.7% | $198.8Mn/m | $1.6Mn/m | -$22.6Mn/m | $51.8M+52.7% | -$10.7Mn/m |
| EPS (Basic) | $0.07n/m | $0.04n/m | $0.19+111.1% | $0.37n/m | $0.00n/m | -$0.04n/m | $0.09+50.0% | -$0.02n/m |
| EPS (Diluted) | $0.07n/m | $0.04n/m | $0.19+111.1% | $0.37n/m | $0.00n/m | -$0.04n/m | $0.09+50.0% | -$0.02n/m |
| Diluted Shares (Avg) | 523M-3.7% | 528M-3.8% | N/A | 539M-2.2% | 543M-4.4% | 548M-3.8% | N/A | 551M-2.8% |
Not reported in any period shown, so not listed: Interest Expense.
PATH Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2710-Q | Q1'2710-Q | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $2.9B+12.2% | $2.9B+9.8% | $3.2B+11.0% | $2.9B+8.7% | $2.6B-4.0% | $2.6B-7.0% | $2.9B-3.0% | $2.7B-4.4% |
| Current Assets | $1.9B-5.1% | $1.9B-9.1% | $2.2B-4.0% | $2.1B-3.8% | $2.0B-10.7% | $2.1B-14.6% | $2.3B-9.4% | $2.2B-10.4% |
| Cash & Equivalents | $607.4M-3.4% | $632.2M-9.8% | $871.2M-0.9% | $743.7M-3.9% | $628.6M-33.1% | $700.6M-38.9% | $879.2M-17.2% | $773.6M-22.9% |
| Short-Term Investments | $676.6M-17.4% | $675.0M-21.0% | $601.3M-19.9% | $654.5M-17.7% | $818.9M+1.8% | $854.4M+8.3% | $750.3M-8.3% | $795.4M-2.3% |
| Accounts Receivable | $307.1M+13.8% | $300.0M+12.5% | $488.3M+8.2% | $366.8M+9.1% | $269.8M+0.8% | $266.6M-1.5% | $451.1M+3.4% | $336.1M-9.9% |
| Long-Term Investments | $121.0M+61.1% | $108.5M+197.5% | $217.0M+130.6% | $121.6M+253.5% | $75.2Mn/m | $36.5M+3690.7% | $94.1Mn/m | $34.4Mn/m |
| Goodwill | $179.5M+48.6% | $185.7M+53.0% | $125.3M+43.5% | $120.6M+34.2% | $120.8M+34.9% | $121.4M+37.3% | $87.3M-1.9% | $89.9M+2.9% |
| Total Liabilities | $958.8M+3.5% | $1.0B+5.9% | $1.1B+7.6% | $971.4M+4.3% | $926.6M+6.8% | $946.0M+15.6% | $1.0B+8.6% | $931.4M+12.8% |
| Current Liabilities | $807.3M+9.3% | $831.7M+16.2% | $905.4M+13.3% | $788.7M+13.4% | $738.4M+16.7% | $715.9M+19.8% | $798.9M+12.3% | $695.5M+10.8% |
| Non-Current Liabilities | $151.6M-19.5% | $170.1M-26.1% | $191.2M-13.3% | $182.7M-22.6% | $188.2M-20.0% | $230.1M+4.4% | $220.6M-2.8% | $236.0M+19.1% |
| Total Equity | $1.9B+17.0% | $1.9B+12.0% | $2.1B+12.8% | $1.9B+11.1% | $1.7B-9.2% | $1.7B-16.2% | $1.8B-8.4% | $1.7B-11.7% |
| Retained Earnings | -$1.6Bn/m | -$1.7Bn/m | -$1.7Bn/m | -$1.8Bn/m | -$2.0Bn/m | -$2.0Bn/m | -$2.0Bn/m | -$2.0Bn/m |
Not reported in any period shown, so not listed: Inventory, Long-Term Debt.
PATH Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2710-Q | Q1'2710-Q | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $30.7M-26.2% | $131.9M+10.9% | $182.3M+24.8% | $28.3M+0.7% | $41.6M-10.3% | $119.0M+19.0% | $146.1M+0.3% | $28.1M-32.9% |
| Depreciation & Amortization | $8.3M+137.1% | $7.5M+130.8% | $5.0M+54.7% | $3.8M0.0% | $3.5M-14.6% | $3.3M-33.6% | $3.2M-46.8% | $3.8M-20.8% |
| Stock-Based Compensation | $45.0M-42.4% | $53.3M-30.2% | N/A | $71.5M-18.3% | $78.0M-17.3% | $76.4M-13.9% | N/A | $87.5M-8.8% |
| Capital Expenditures | $1.4Mn/m | $2.7M-79.1% | $3.1M-58.7% | $3.2M-35.1% | $0-100.0% | $12.8M+936.5% | $7.4M+95.3% | $4.9M+614.8% |
| Free Cash Flow | $29.3M-29.5% | $129.2M+21.7% | $179.3M+29.3% | $25.1M+8.2% | $41.6M-7.5% | $106.2M+7.5% | $138.7M-2.2% | $23.2M-43.7% |
| Investing Cash Flow | -$15.7Mn/m | -$112.8Mn/m | -$42.7Mn/m | $100.8Mn/m | -$655Kn/m | -$79.9M-323.5% | -$16.7Mn/m | -$22.9Mn/m |
| Financing Cash Flow | -$34.9Mn/m | -$252.2Mn/m | -$14.4Mn/m | -$11.2Mn/m | -$111.6Mn/m | -$235.2Mn/m | -$17.0Mn/m | -$172.6Mn/m |
| Share Buybacks | $24.8M-75.6% | $243.8M+7.2% | $0-100.0% | $0-100.0% | $101.6M-48.4% | $227.5M+934.0% | $9.3M-81.3% | $162.7M+208.9% |
Not reported in any period shown, so not listed: Dividends Paid.
PATH Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2710-Q | Q1'2710-Q | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 80.4%-1.8pp | 81.6%-0.5pp | 84.6%-0.1pp | 83.3%+1.2pp | 82.2%+2.2pp | 82.1%-1.4pp | 84.8%-2.1pp | 82.0%-2.7pp |
| Operating Margin | 7.7%+13.3pp | 6.7%+11.3pp | 16.7%+8.8pp | 3.2%+15.4pp | -5.6%+27.1pp | -4.6%+10.2pp | 7.9%+4.2pp | -12.2%+4.9pp |
| Net Margin | 8.8%+8.4pp | 5.4%+11.7pp | 21.7%+9.5pp | 48.4%+51.4pp | 0.4%+27.7pp | -6.3%+2.3pp | 12.2%+3.9pp | -3.0%+6.7pp |
| Return on Equity | 1.8%+1.7pp | 1.2%+2.5pp | 5.0%+2.2pp | 10.3%+10.9pp | 0.1%+4.8pp | -1.3%+0.1pp | 2.8%+1.1pp | -0.6%+1.0pp |
| Return on Assets | 1.2%+1.2pp | 0.8%+1.6pp | 3.3%+1.5pp | 6.9%+7.3pp | 0.1%+3.3pp | -0.9%+0.2pp | 1.8%+0.7pp | -0.4%+0.7pp |
| Current Ratio | 2.39-0.4x | 2.31-0.6x | 2.48-0.4x | 2.65-0.5x | 2.75-0.8x | 2.95-1.2x | 2.93-0.7x | 3.13-0.7x |
| Liabilities-to-Equity | 0.49-0.1x | 0.530.0x | 0.530.0x | 0.500.0x | 0.56+0.1x | 0.56+0.2x | 0.55+0.1x | 0.54+0.1x |
| Asset Turnover | 0.140.0x | 0.140.0x | 0.150.0x | 0.140.0x | 0.140.0x | 0.130.0x | 0.150.0x | 0.130.0x |
| FCF Margin | 7.1%-4.4pp | 30.9%+1.1pp | 37.3%+4.5pp | 6.1%-0.4pp | 11.5%-2.7pp | 29.8%+0.3pp | 32.7%-2.2pp | 6.5%-6.1pp |
Not reported in any period shown, so not listed: Debt-to-Equity.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| UiPath, Inc. PATH | FY2026 | $1.6B | $282.3M | 17.5% | $7.4B | 57/100 |
| Varonis Systems, Inc. VRNS | FY2025 | $623.5M | -$129.3M | -20.7% | $5.6B | 65/100 |
| SentinelOne, Inc. S | FY2026 | $1.0B | -$450.7M | -45.0% | $8.4B | 45/100 |
| WEX Inc. WEX | FY2025 | $2.7B | $304.1M | 11.4% | $6.7B | 54/100 |
Where UiPath, Inc. Ranks
Frequently Asked Questions
What is UiPath, Inc.'s annual revenue?
UiPath, Inc. (PATH) reported $1.6B in total revenue for fiscal year 2026. This represents a 12.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is UiPath, Inc.'s revenue growing?
UiPath, Inc. (PATH) revenue grew by 12.7% year-over-year, from $1.4B to $1.6B in fiscal year 2026.
Is UiPath, Inc. profitable?
Yes, UiPath, Inc. (PATH) reported a net income of $361.9M over the trailing 12 months to July 31, 2026. In fiscal year 2026 it reported a net income of $282.3M, with a net profit margin of 17.5%.
What is UiPath, Inc.'s EBITDA?
UiPath, Inc. (PATH) had EBITDA of $73.7M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.
What is UiPath, Inc.'s gross margin?
UiPath, Inc. (PATH) had a gross margin of 83.2% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.
What is UiPath, Inc.'s operating margin?
UiPath, Inc. (PATH) had an operating margin of 3.5% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.
What is UiPath, Inc.'s net profit margin?
UiPath, Inc. (PATH) had a net profit margin of 17.5% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.
What is UiPath, Inc.'s return on equity (ROE)?
UiPath, Inc. (PATH) has a return on equity of 13.6% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.
What is UiPath, Inc.'s free cash flow?
UiPath, Inc. (PATH) generated $352.2M in free cash flow during fiscal year 2026. This represents a 15.2% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is UiPath, Inc.'s operating cash flow?
UiPath, Inc. (PATH) generated $371.2M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.
What are UiPath, Inc.'s total assets?
UiPath, Inc. (PATH) had $3.2B in total assets as of fiscal year 2026, including both current and long-term assets.
What are UiPath, Inc.'s capital expenditures?
UiPath, Inc. (PATH) invested $19.0M in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.
How much does UiPath, Inc. spend on research and development?
UiPath, Inc. (PATH) invested $385.2M in research and development during fiscal year 2026.
What is UiPath, Inc.'s current ratio?
UiPath, Inc. (PATH) had a current ratio of 2.48 as of fiscal year 2026, which is generally considered healthy.
What is UiPath, Inc.'s liabilities-to-equity ratio?
UiPath, Inc. (PATH) had a liabilities-to-equity ratio of 0.53 as of fiscal year 2026, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity. No debt-to-equity ratio is shown for fiscal year 2026, because the filing data we hold for that year carries no long-term debt figure.
What is UiPath, Inc.'s return on assets (ROA)?
UiPath, Inc. (PATH) had a return on assets of 8.9% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.
What is UiPath, Inc.'s P/E ratio?
UiPath, Inc. (PATH) trades at 20.3x earnings, its market capitalization divided by $361.9M net income, trailing 12 months to July 31, 2026. The market capitalization is $7.4B as of Oct 23, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is UiPath, Inc.'s price-to-sales ratio?
UiPath, Inc. (PATH) trades at 4.3x sales, its market capitalization divided by $1.7B revenue, trailing 12 months to July 31, 2026. The market capitalization is $7.4B as of Oct 23, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is UiPath, Inc.'s Altman Z-Score?
UiPath, Inc. (PATH) has an Altman Z-Score of 4.35, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is UiPath, Inc.'s Piotroski F-Score?
UiPath, Inc. (PATH) has a Piotroski F-Score of 6 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are UiPath, Inc.'s earnings high quality?
UiPath, Inc. (PATH) has an earnings quality ratio of 1.31x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is UiPath, Inc.?
UiPath, Inc. (PATH) scores 57 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.